Assignee
M et P Pharma AG
CH·7 granted patents·2 pending applications·10 citations·filing 2015–2021
Top patents by PatentIndex Score
9 records- 0191US9962394B2Controlled release delivery system for nasal applications and method of treatmentM et P Pharma AG·Filed 2017·Granted May 8, 2018·4 cites·16 claims
- 0287US10596181B2Treatment of demyelinating diseasesM et P Pharma AG·Filed 2019·Granted Mar 24, 2020·2 cites·16 claims
- 0383US9801834B2Controlled release delivery system for nasal application of neurotransmittersM et P Pharma AG·Filed 2015·Granted Oct 31, 2017·3 cites·10 claims
- 0482US10898495B2Treatment of demyelinating diseasesM et P Pharma AG·Filed 2020·Granted Jan 26, 2021·1 cites·13 claims
- 0571US11723911B2Treatment of demyelinating diseasesM et P Pharma AG·Filed 2021·Granted Aug 15, 2023·0 cites·20 claims
- 0658US2018200203A1Controlled release delivery system for nasal application of neurotransmittersM et P Pharma AG·Filed 2017·Application pending·0 cites
- 0754US10729646B2Nasal pharmaceutical compositions for reducing the risks of exposure to air pollutantsM et P Pharma AG·Filed 2018·Granted Aug 4, 2020·0 cites·21 claims
- 0848US11903951B2Nasal pharmaceutical compositions with a porous excipientM et P Pharma AG·Filed 2017·Granted Feb 20, 2024·0 cites·19 claims
- 0945US2022062165A1Compositions and methods for intranasal delivery of pregnenoloneM et P Pharma AG·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when M et P Pharma AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →